anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

119,701-119,760 of 319,975

filter-aware
01
Slide 1
Includes a testimonial/marketing image from Apellis featuring Henry Winkler.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Loop · Cost Of Inaction1 hit
02
The slide uses a 'jumped the shark' idiom to frame the drug's clinical reception as having peaked and begun a decline in credibility.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The MonsterLoop · Cost Of Inaction1 hit
03
Uses a 'Moneyball' quote to frame the argument against the drug's clinical performance.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The MonsterLoop · Cost Of Inaction1 hit
04
The slide uses screenshots of a presentation to illustrate the doctor's arguments, which Citron then undermines by pointing out financial incentives.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The MonsterLoop · Cost Of Inaction1 hit
05
Includes a screenshot of a presentation slide from Dr. William Johnson and a donut chart showing 83% vs 17% sentiment.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The MonsterLoop · Cost Of Inaction1 hit
06
The slide contains two embedded screenshots of presentation slides (Results and Conclusions) and a testimonial from Dr. Suber Huang.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
07
Includes a direct quote from an earnings call and a chart from a Jefferies analyst report.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The StruggleLoop · Cost Of Inaction1 hit
08
The slide uses screenshots of FDA Adverse Event Reporting System documents to support the claim of securities fraud.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The StruggleLoop · The Reveal1 hit
09
The slide presents raw FOIA-sourced data tables for specific patient cases.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Loop · The Reveal1 hit
10
The slide presents raw data from FDA adverse event reports, highlighting specific medical events associated with Syfovre usage.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Loop · Cost Of Inaction1 hit
11
Includes two FOIA data tables as evidence of adverse events.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Loop · Cost Of Inaction1 hit
12
Includes a specific reference to a 'Fonzi Scheme' analogy regarding One Reverse Mortgages.Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
13
Apellis Pharmaceuticals (APLS)Apellis Pharmaceuticals (APLS) · Citron Research
Research note Short seller Beat · The VictoryLoop · Cost Of Inaction1 hit
01
Slide 1
The slide uses a narrative-driven structure to build credibility for the investment thesis.Nebius Group (NBIS) · Citron Research
Research note Short seller Beat · AttentionLoop · Golden Circle1 hit
02
Includes a disclaimer section at the bottom.Nebius Group (NBIS) · Citron Research
Research note Short seller Beat · InterestLoop · Golden Circle1 hit
03
Nebius Group (NBIS)Nebius Group (NBIS) · Citron Research
Research note Short seller Beat · Desire1 hit
01
Slide 1
The slide serves as a retrospective performance review of specific short-selling research reports.Multiple (portfolio update) · Citron Research
Research note Short seller Beat · Attention1 hit
02
The slide acts as a summary of investment thesis updates for three specific companies.Multiple (portfolio update) · Citron Research
Research note Short seller Beat · Interest1 hit
03
The slide serves as a post-mortem analysis of investment failures, incorporating a Warren Buffett quote to reinforce the thesis.Multiple (portfolio update) · Citron Research
Research note Short seller Beat · DesireLoop · Cost Of Inaction1 hit
04
Multiple (portfolio update)Multiple (portfolio update) · Citron Research
Research note Short seller 1 hit
05
Multiple (portfolio update)Multiple (portfolio update) · Citron Research
Research note Short seller 1 hit
01
Slide 1
The slide uses a billboard metaphor to visually represent the reversal of the firm's previous skeptical stance.Credit Acceptance Corporation (CACC) · Citron Research
Research note Short seller Beat · ProblemLoop · Hypothesis Test1 hit
02
The slide uses a 'mea culpa' narrative style to build credibility for a new investment thesis.Credit Acceptance Corporation (CACC) · Citron Research
Research note Short seller Beat · ProblemLoop · Cost Of Inaction1 hit
03
Uses a 'whataboutism' rhetorical strategy to defend CACC's business model against ethical criticism.Credit Acceptance Corporation (CACC) · Citron Research
Research note Short seller Beat · ProblemLoop · Cost Of Inaction1 hit
04
The slide uses a 'valuation_table' to demonstrate the upside potential based on different P/E multiples.Credit Acceptance Corporation (CACC) · Citron Research
Research note Short seller Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a 'moat' narrative to explain why the company's business model is defensible against competitors like Carvana and DriveTime.Credit Acceptance Corporation (CACC) · Citron Research
Research note Short seller Beat · AgitateLoop · Cost Of Inaction1 hit
01
Slide 1
The slide uses external news headlines as social proof to validate a bullish thesis on Edgio.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
02
Citron Research note using external validation to support a stock recommendation.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Problem (Identify pain)Loop · Cost Of Inaction1 hit
03
The slide uses a comparative valuation framework to argue for a significant upside in Edgio's stock price based on peer multiples.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Agitate (Make it worse)1 hit
04
The slide uses third-party validation (AWS/Microsoft) to counter potential skepticism about Edgio's capabilities.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Agitate (Make it worse)Loop · Zoom In1 hit
05
The slide uses a list-based comparison rather than a table grid to contrast two product tiers.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Agitate (Make it worse)Loop · Zoom In1 hit
06
The slide uses a screenshot of a BrightTALK webinar as evidence of the partnership.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Solution (Provide relief)1 hit
07
The slide uses a screenshot of a third-party comparison table to support a thesis about market share shift.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Solution (Provide relief)1 hit
08
The slide uses a Q&A format to address market misconceptions about Edgio's relationship with Azure and its business viability.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Solution (Provide relief)1 hit
09
The slide contrasts past leadership failures with current leadership's forward-looking statements.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Solution (Provide relief)1 hit
10
The slide contains a mix of operational metrics, board member bios, and financial performance indicators.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller Beat · Solution (Provide relief)1 hit
11
Includes a disclaimer regarding Lynrock warrants and a standard Citron Research legal disclaimer.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller 1 hit
12
This is a standard legal boilerplate page found in investment research reports.Edgio, Inc. (EGIO) · Citron Research
Research note Short seller 1 hit
13
Edgio, Inc. (EGIO)Edgio, Inc. (EGIO) · Citron Research
Research note Short seller 1 hit
01
Slide 1
The slide uses a 'Forbes 30 under 30' cover as a visual anchor for the 'curse' narrative.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · HookLoop · Cost Of Inaction1 hit
02
The slide uses a screenshot of a sanctions database entry to discredit the subject's public statements.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · Expose ContradictionLoop · Pattern Hunter1 hit
03
The slide uses a rhetorical question to frame the company as a 'Belize/Russian version of Alameda Research'.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · Expose ContradictionLoop · Pattern Hunter1 hit
04
The slide uses a 'fraud-exposure' framework to link the CEO's ownership of FFIN to potential earnings manipulation.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · Expose ContradictionLoop · Pattern Hunter1 hit
05
The slide uses a screenshot of a PCAOB document to establish credibility and then quotes specific findings regarding audit failures, concluding with a call for delisting.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · Expose ContradictionLoop · Pattern Hunter1 hit
06
The slide uses a comparison-frame to link Freedom Holdings to the FTX scandal, highlighting governance and regulatory risks.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Loop · Cost Of Inaction1 hit
07
The slide contains a highlighted sentence at the top that appears to be a carry-over from a previous page.Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · DisclaimerLoop · Cost Of Inaction1 hit
08
Freedom Holding Corp (FRHC)Freedom Holding Corp (FRHC) · Citron Research
Research note Short seller Beat · DisclaimerLoop · Cost Of Inaction1 hit
01
Slide 1
The slide uses a 'connecting the dots' narrative structure to link VPG's design wins to Tesla's product roadmap.Vishay Precision Group (VPG) · Citron Research
Research note Short seller Beat · ProblemLoop · Cost Of Inaction1 hit
02
Includes a screenshot of a LinkedIn post by Brett Adcock regarding Figure AI.Vishay Precision Group (VPG) · Citron Research
Research note Short seller Beat · SolutionLoop · Cost Of Inaction1 hit
03
The slide functions as a summary/conclusion page for a Citron Research report, including a financial snapshot and mandatory legal disclosures.Vishay Precision Group (VPG) · Citron Research
Research note Short seller Beat · EvidenceLoop · Cost Of Inaction1 hit
04
This is a full-page legal text block.Vishay Precision Group (VPG) · Citron Research
Research note Short seller 1 hit
01
Slide 1
The slide serves as a short-seller research note update.NIO Inc. (NIO) · Citron Research
Research note Short seller Beat · Situation & Context1 hit
02
The slide uses quotes from Deutsche Bank, Tianfeng Securities, and Bloomberg to build a bearish case against NIO based on Tesla's pricing power.NIO Inc. (NIO) · Citron Research
Research note Short seller Beat · Problem & ComplicationLoop · Pattern Hunter1 hit
03
The slide uses a bearish tone to critique NIO's valuation and investor base.NIO Inc. (NIO) · Citron Research
Research note Short seller Beat · Evidence & ProofLoop · Pattern Hunter1 hit
04
The slide contains a brief bearish call on NIO at the top, followed by extensive legal boilerplate.NIO Inc. (NIO) · Citron Research
Research note Short seller Beat · Impact & Next Steps1 hit
05
NIO Inc. (NIO)NIO Inc. (NIO) · Citron Research
Research note Short seller Beat · Impact & Next Steps1 hit
10
The slide uses a skeptical tone to argue that Peloton's valuation is disconnected from reality and that management is preparing to exit.Peloton Interactive (PTON) · Citron Research
Research note Short seller Beat · The StruggleLoop · Hypothesis Test1 hit
11
Citron Research short thesis slide.Peloton Interactive (PTON) · Citron Research
Research note Short seller Beat · The Victory1 hit
12
Includes a specific note to the reader regarding Peloton's valuation and market expectations.Peloton Interactive (PTON) · Citron Research
Research note Short seller Beat · The Victory1 hit
13
Peloton Interactive (PTON)Peloton Interactive (PTON) · Citron Research
Research note Short seller Beat · The Victory1 hit